A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction
Completed · Phase 4
Conditions studied: Mastectomy Related Lymphedema, Breast Reconstruction, Breast Cancer
In brief
Breast Cancer affects about 1 out of 8 American women. Twenty percent of breast cancer patients undergo some form of breast reconstruction. Several types of reconstructive procedures are available for appropriate patients. A reconstructive sequence consisting of a tissue expander followed by permanent implant placement is a popular choice for many women. In the past several years, acellular dermal matrices (allografts) have been used at the time of tissue expander placement to extend submuscular coverage. Reported benefits include the ability to initially fill the expander to a greater extent, improved control of the inframammary crease, and possible decrease in capsular contracture rate. Potential disadvantages of dermal allografts include foreign body reaction, incomplete tissue integration, or increased infection rates. The latter is especially worrisome, as infection in the setting of a tissue expander often necessitates the removal of the implant and interruption of the reconstructive sequence. There have been a few scattered reports of the use of dermal autografts in implant-based breast reconstruction, but they have not been widely used. Dermal autografts carry the potential benefit of improved tissue integration and lowered complication rates. However, to date there have been no studies which compare acellular dermal allograft matrices to dermal autograft for use in breast reconstruction. The objectives of this study are to compare dermal allograft to dermal autograft with respect to cost, tissue integration, patient satisfaction with scar, and complication profile in patients undergoing mastectomy followed by tissue expander/implant reconstruction.
Key facts
- Study ID
- NCT01561287
- Run by
- University of Kentucky
- People needed
- 48
- Starts
- 2011-07-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2016-05-11
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Only patients who underwent tissue expander/implant breast reconstruction will be included
You may not qualify if…
- Patients without the presence of breast cancer or with the presence of the BRCA gene will be excluded
Where it is running
- University of Kentucky Chandler Medical Center — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.